SYS-CON MEDIA Authors: Michael Jannery, Pat Romanski, Elizabeth White, Liz McMillan, Plutora Blog

News Feed Item

Epilepsy Foundation Presents Lifetime Accelerator Award to H. Steven White, Ph.D., for Contributions to the Field of Epilepsy and Seizures

Dr. White to Be Honored at 4th Biennial Epilepsy Pipeline Conference 2014 in San Francisco June 5-7

LANDOVER, MD--(Marketwired - May 29, 2014) - The Epilepsy Foundation announced today that H. Steven White, Ph.D., professor of pharmacology and toxicology and principal investigator of the National Institutes of Health (NIH)-sponsored Anticonvulsant Drug Development Program at the University of Utah College of Pharmacy, has been named the 2014 recipient of the Epilepsy Foundation's Lifetime Accelerator Award, in recognition of his commitment and pioneering contributions to the field of epilepsy and seizures. Dr. White will be honored at the 4th Biennial Epilepsy Pipeline Conference 2014, being held June 5-7, 2014, at the Hyatt Regency San Francisco.

A leader in translational research in anticonvulsant drug therapies, Dr. White is well-recognized for his scientific leadership of the University of Utah NIH-sponsored Anticonvulsant Drug Development (ADD) Program, founded in 1975 by the late Ewart A. Swinyard in collaboration with the National Institutes of Neurological Disorders and Stroke (NINDS), NIH. Dr. White's career in antiepileptic drug discovery began in 1986 as the senior scientist of the ADD Program. Over the three decades that mark Dr. White's research in the field, this program has played a crucial role in the early identification and characterization of thousands of novel anticonvulsant medications using established seizure and epilepsy models. Dr. White's laboratory has identified and characterized the anticonvulsant profile and potential mechanism of action for established and new anti-epilepsy agents. Notably, the efforts of the faculty, staff and students of this program, which Dr. White has directed since 2001, have since its establishment in 1975 contributed to the successful development of multiple new therapeutics, including felbamate, rufinamide, topiramate, retigabine and lacosamide.

"On behalf of the Epilepsy Foundation and many clinicians treating seizure conditions today, we are especially pleased to honor Dr. White with the Lifetime Accelerator Award and to recognize his outstanding contributions in anticonvulsant drug development," said Philip M. Gattone, president and CEO of the Epilepsy Foundation. "We are grateful not only for his steadfast commitment to our mission, but also for his energy and enthusiasm for mentoring the next generation of neuroscientists and epilepsy educators."

"Dr. White has been a force behind many of the therapeutics used in treatment today. He is truly dedicated to finding therapies that will make a difference to patients through development of new animal models," said Jacqueline A. French, M.D., director of the Epilepsy Study Consortium, and director of clinical trials at NYU's Comprehensive Epilepsy Center. "He has given generously of his free time to collaborate with other researchers and epilepsy organizations and this recognition is well-deserved."

Ongoing translational research in Dr. White's laboratory is focused on the development of novel models of therapy resistant models and understanding the influence of genetics on the pathophysiology, seizure-susceptibility and anti-epileptic drug pharmacology of animal seizure and epilepsy models. Dr. White and his colleagues at Utah and the NINDS are conducting research that may lead to novel therapies for treatment-resistant epilepsy and importantly, disease-modifying therapies with the potential to halt, slow, or prevent the development of epilepsy in susceptible individuals. He is also a scientific co-founder of NeuroAdjuvants, Inc., a Salt Lake City-based biotechnology firm focused on the development of metabolically stable, blood-brain-barrier neuropeptides for the treatment of refractory epilepsy and pain.

Dr. White earned his Ph.D. in Pharmacology in 1984 at the University of Utah and an M.S. in Pharmacology and baccalaureate degree in Pharmacy at Idaho State University. He began his career as a practicing pharmacist and since 1984 has risen through the academic ranks at the University of Utah. On November 18, 2011, Dr. White received an Honorary Doctor of Science from The University of Copenhagen Faculty of Pharmaceutical Sciences, Copenhagen, Denmark. Over the years, Dr. White has been the recipient of significant research funding from the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), and he and his collaborators have published over 170 original papers pertaining to the mechanism of action and the pharmacology of antiepileptic drugs. In addition to his academic service, Dr. White has served as Research Director of CURE (Citizen's United for Research in Epilepsy), the largest non-governmental provider of epilepsy research funding, since November 2011.

Epilepsy Foundation's Lifetime Accelerator Award
The Lifetime Accelerator Award was established in 2012 to honor physicians, scientists, industry leaders, and other individuals who have demonstrated a lifelong commitment to bringing new therapies to people living with epilepsy. Lifetime Accelerator Award recipients are chosen by an independent committee of global thought leaders and clinical investigators in epilepsy and seizure therapy discovery and development. Harvey Kupferberg, Ph.D., past chief of the Preclinical Pharmacology Section, Epilepsy Branch, NINDS, NIH, was conferred the 2012 Lifetime Accelerator Award, and Henrik Klitgaard, Ph.D., vice president, head CNS research, UCB, received the award in 2013. 

About Epilepsy
When a person has two or more unprovoked seizures, they have epilepsy, which affects more than 2 million people in the United States and 65 million people worldwide. This year, another 150,000 people in our country will be diagnosed with epilepsy. Despite all available treatments, four out of 10 people with epilepsy continue to experience uncontrolled seizures while many more experience less than optimal seizure control.

About the Epilepsy Foundation
The Epilepsy Foundation, a national non-profit with 48 affiliated organizations throughout the United States, has led the fight against seizures since 1968. The Foundation is an unwavering ally for individuals and families impacted by epilepsy and seizures. The mission of the Epilepsy Foundation is to stop seizures and sudden unexpected death in epilepsy (SUDEP), find a cure and overcome the challenges created by epilepsy through efforts including education, advocacy and research to accelerate ideas into therapies. The Foundation works to ensure that people with seizures have the opportunity to live their lives to their fullest potential. For additional information, please visit www.epilepsy.com.

"Like" the Epilepsy Foundation on Facebook at www.facebook.com/epilepsyfoundationofamerica and follow us on Twitter at www.twitter.com/epilepsyfdn

The following files are available for download:

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
The 4th International DevOps Summit, co-located with16th International Cloud Expo – being held June 9-11, 2015, at the Javits Center in New York City, NY – announces that its Call for Papers is now open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the world's large...
CA Technologies released a new study – “DevOps: The Worst-Kept Secret to Winning in the Application Economy” – that reveals that 82% of enterprises in Asia Pacific and Japan (APJ) already have or plan to adopt a DevOps strategy, a 12 point increase from last year’s figure of 70%. DevOps is a methodology which helps foster collaboration between the teams that create and test applications (Dev) with those that maintain them in production environments (Ops). Vanson Bourne conducted the survey with...
Enthusiasm for the Internet of Things has reached an all-time high. In 2013 alone, venture capitalists spent more than $1 billion dollars investing in the IoT space. With "smart" appliances and devices, IoT covers wearable smart devices, cloud services to hardware companies. Nest, a Google company, detects temperatures inside homes and automatically adjusts it by tracking its user's habit. These technologies are quickly developing and with it come challenges such as bridging infrastructure gaps,...
“The year of the cloud – we have no idea when it's really happening but we think it's happening now. For those technology providers like Zentera that are helping enterprises move to the cloud - it's been fun to watch," noted Mike Loftus, VP Product Management and Marketing at Zentera Systems, in this SYS-CON.tv interview at Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The Domain Name Service (DNS) is one of the most important components in networking infrastructure, enabling users and services to access applications by translating URLs (names) into IP addresses (numbers). Because every icon and URL and all embedded content on a website requires a DNS lookup loading complex sites necessitates hundreds of DNS queries. In addition, as more internet-enabled ‘Things' get connected, people will rely on DNS to name and find their fridges, toasters and toilets. Acco...
“This win means a great deal to us because it is decided by the readers – the people who understand how use of our technology enables new insights that drive the business,” said Matt Davies, senior director, EMEA marketing, Splunk. “Splunk Enterprise enables organizations to improve service levels, reduce operations costs, mitigate security risks, enhance DevOps collaboration, create new product and service offerings and obtain deeper insight into customer behavior. Being named Best Business App...
Today’s enterprise is being driven by disruptive competitive and human capital requirements to provide enterprise application access through not only desktops, but also mobile devices. To retrofit existing programs across all these devices using traditional programming methods is very costly and time consuming – often prohibitively so. In his session at @ThingsExpo, Jesse Shiah, CEO, President, and Co-Founder of AgilePoint Inc., discussed how you can create applications that run on all mobile ...
"SOASTA built the concept of cloud testing in 2008. It's grown from rather meager beginnings to where now we are provisioning hundreds of thousands of servers on a daily basis on behalf of customers around the world to test their applications," explained Tom Lounibos, CEO of SOASTA, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"Verizon Digital Media Services is responsible for the broadcast, video and content delivery network that accelerates, scales and helps our customers reach end users with all kinds of video and web content," stated James Segil, CMO of Verizon Digital Media Services, in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
The cloud has transformed how we think about software quality. Instead of preventing failures, we must focus on automatic recovery from failure. In other words, resilience trumps traditional quality measures. Continuous delivery models further squeeze traditional notions of quality. Remember the venerable project management Iron Triangle? Among time, scope, and cost, you can only fix two or quality will suffer. Only in today's DevOps world, continuous testing, integration, and deployment upend...
The Internet of Things is a misnomer. That implies that everything is on the Internet, and that simply should not be - especially for things that are blurring the line between medical devices that stimulate like a pacemaker and quantified self-sensors like a pedometer or pulse tracker. The mesh of things that we manage must be segmented into zones of trust for sensing data, transmitting data, receiving command and control administrative changes, and peer-to-peer mesh messaging. In his session a...
“We are a managed services company. We have taken the key aspects of the cloud and the purposed data center and merged the two together and launched the Purposed Cloud about 18–24 months ago," explained Chetan Patwardhan, CEO of Stratogent, in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"For over 25 years we have been working with a lot of enterprise customers and we have seen how companies create applications. And now that we have moved to cloud computing, mobile, social and the Internet of Things, we see that the market needs a new way of creating applications," stated Jesse Shiah, CEO, President and Co-Founder of AgilePoint Inc., in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
You use an agile process; your goal is to make your organization more agile. But what about your data infrastructure? The truth is, today's databases are anything but agile - they are effectively static repositories that are cumbersome to work with, difficult to change, and cannot keep pace with application demands. Performance suffers as a result, and it takes far longer than it should to deliver new features and capabilities needed to make your organization competitive. As your application an...
SAP is delivering break-through innovation combined with fantastic user experience powered by the market-leading in-memory technology, SAP HANA. In his General Session at 15th Cloud Expo, Thorsten Leiduck, VP ISVs & Digital Commerce, SAP, discussed how SAP and partners provide cloud and hybrid cloud solutions as well as real-time Big Data offerings that help companies of all sizes and industries run better. SAP launched an application challenge to award the most innovative SAP HANA and SAP HANA...